soretolide
structure given in first source
Also Known As:
2,6-dimethylbenzamide-N-(5-methyl-3-isoxazole); D 2916; D2916
Networked: 2
relevant articles (0 outcomes,
1 trials/studies)
Bio-Agent Context: Research Results
Experts
Related Diseases
1. | Epilepsy (Aura)
06/01/2001
- " Laboratoires Biocodex is developing soretolide (D-2916) as a potential treatment for epilepsy. " 10/01/1999
- " In this review, we consider the possible physiological targets for anti-epileptic drugs, the animal models of epilepsy, problems with clinical trials and ten promising anti-epileptic drugs in development (AWD 131-138, DP16 (DP-VPA), ganaxolone, levetiracetam, losigamone, pregabalin, remacemide, retigabine, rufinamide and soretolide). "
|
2. | Seizures (Absence Seizure)
|
|
Related Drugs and Biologics